Influence of Cytokine Gene Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer after Radical Prostatectomy

被引:12
|
作者
Lin, Han-Ching [1 ,2 ]
Liu, Chia-Chu [1 ]
Kang, Wan-Yi [3 ]
Yu, Chia-Cheng [4 ]
Wu, Tony T. [4 ]
Wang, Jyh-Seng [5 ]
Wu, Wen-Jeng [1 ,8 ]
Huang, Chun-Hsiung [1 ,8 ]
Wu, Ming-Tsang [6 ,7 ]
Huang, Shu-Pin [1 ,8 ,9 ]
机构
[1] Kaohsiung Med Univ & Hosp, Dept Urol, Kaohsiung 807, Taiwan
[2] Antai Tian Sheng Mem Hosp, Dept Urol, Donggang, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan
[4] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan
[5] Kaohsiung Vet Gen Hosp, Dept Pathol, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan
[7] Kaohsiung Med Univ, Coll Med, Fac Med, Grad Inst Occupat Safety & Hlth, Kaohsiung, Taiwan
[8] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan
[9] Kaohsiung Municipal Hsiaokang Hosp, Dept Urol, Kaohsiung, Taiwan
关键词
Prostate cancer; Cytokine; Genetic polymorphisms; Prostate-specific antigen; AUTOCRINE GROWTH-FACTOR; RETROPUBIC PROSTATECTOMY; INTERLEUKIN-6; RISK; ASSOCIATION; SURVIVAL; RECEPTOR; TUMORIGENICITY; ANGIOGENESIS; PROGRESSION;
D O I
10.1159/000251189
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Evidence is accumulating indicating that chronic inflammation plays an important role in prostate cancer. We investigated the potential prognostic roles of IL-6, IL-8 and IL-10 polymorphisms in clinical localized prostate cancer after radical prostatectomy. Materials and Methods: A total of 116 clinically localized prostate cancer patients undergoing curative radical prostatectomy were included in this study. The IL-6, IL-8 and IL-10 polymorphisms were determined by the TaqMan real-time PCR method. Their prognostic significance on prostate-specific antigen (PSA) recurrence was assessed using Kaplan-Meier analysis and Cox regression model. Results: The IL-6 polymorphism (rs2066992) T/G and G/G genotype cases were associated with a higher percentage of preoperative PSA levels of >= 10 ng/ml; higher risk of positive surgical margin, and higher risk of extraprostatic extension compared to the T/T genotype. The IL-10 polymorphism (rs1800871) A/A genotype was associated with a higher risk of PSA recurrence compared with the A/G + G/G genotypes and significantly poorer PSA-free survival (log-rank test, p = 0.019). After considering other covariates in a Cox proportional hazard model, the IL-10 A/A genotype and high Gleason score (8-10) were still independent predictors of poor PSA-free survival. Conclusion: Our results suggest that the IL-10 polymorphism may be a prognostic factor for PSA recurrence after radical prostatectomy. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [41] Management of patients with an increasing prostate-specific antigen after radical prostatectomy
    Khan M.A.
    Partin A.W.
    [J]. Current Urology Reports, 2004, 5 (3) : 179 - 187
  • [42] Radiotherapy after radical prostatectomy in patients with prostate-specific antigen elevation
    Wiegel, T
    Hinkelbein, W
    [J]. CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 35 - 42
  • [43] Prostate-specific antigen levels after radical prostatectomy versus brachytherapy
    Merrick, GS
    Butler, WM
    Grimm, PD
    [J]. UROLOGY, 1999, 53 (04) : 865 - 866
  • [44] Re: Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Shteynshlyuger, Alex
    Kibel, Adam S.
    [J]. EUROPEAN UROLOGY, 2009, 56 (06) : 1089 - 1090
  • [45] Influence of digital rectal massage on urinary prostate-specific antigen:: Interest for the detection of local recurrence after radical prostatectomy
    Malavaud, B
    Salama, G
    Miédougé, M
    Vincent, C
    Rischmann, P
    Sarramon, JP
    Serre, G
    [J]. PROSTATE, 1998, 34 (01): : 23 - 28
  • [46] Is there a prostate-specific antigen upper limit for radical prostatectomy?
    Gontero, Paulo
    Spahn, Martin
    Tombal, Bertrand
    Bader, Pia
    Hsu, Chao-Yu
    Marchioro, Giansilvio
    Frea, Bruno
    Van der Eeckt, Kathy
    Kneitz, Burkhard
    Frohneberg, Detlef
    Tizzani, Alessandro
    Van Poppel, Hendrik
    Joniau, Steven
    [J]. BJU INTERNATIONAL, 2011, 108 (07) : 1093 - 1100
  • [47] Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
    Tilki, Derya
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Mohamad, Osama
    Cowan, Janet E.
    Feng, Felix Y.
    Carroll, Peter R.
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) : 2428 - +
  • [48] Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical 14 retropubic prostatectomy for localized prostate cancer?
    Haukaas, SA
    Halvorsen, OJ
    Daehlin, L
    Hostmark, J
    Akslen, LA
    [J]. BJU INTERNATIONAL, 2006, 97 (01) : 51 - 55
  • [49] ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO NADIR AS INDEPENDENT PREDICTORS OF BIOCHEMICAL RECURRENCE IN PATIENTS AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER
    Vesely, S.
    Jarolim, L.
    Babjuk, M.
    Dusek, P.
    Kaliska, V.
    Schmidt, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 274 - 274
  • [50] Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Fondurulia, J
    Chen, MH
    Kaplan, I
    Beard, CJ
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Coleman, CN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 168 - 172